Naprosyn contains Naproxen and is indicated for the symptomatic treatment of: rheumatoid arthritis, osteoarthritis (degenerative arthritis), ankylosing spondylitis, gouty arthropathy and various forms of extra-articular rheumatism (lumbosciatica, myalgia, neuralgia, radicular syndromes, periarthritis, fibromyositis).
Active ingredient
Naproxen 250 mg.
Excipients
Sodium chloride, sodium dioctyl sulfosuccinate, povidone, mint flavoring, anise mint flavoring, mannitol, sodium saccharinate, sucrose.
How to use
Adults: As an attack therapy, the administration of 500-1000 mg per day is recommended, divided into two doses, 12 hours apart. The dose of 1000 mg per day in a single administration is recommended: in subjects with severe night pain and/or morning stiffness, in patients already treated unsuccessfully with other high-dose antirheumatic drugs, in osteoarthritis when pain is the predominant symptom.
As maintenance therapy, a daily dose of 750-250 mg is indicated in a single administration or in two administrations at 12-hour intervals. In acute gout attacks, an initial dose of 500 mg is recommended, followed by doses of 250 mg every 8 hours in the first 24 hours, subsequently moving to maintenance doses of 250 mg twice a day for 6-7 days.
Children: the product is not intended for use in pediatric age, except, at the discretion of the doctor, in cases of absolute necessity in children over 2 years of age.
ILCLOSED LEAFLET
Product images are purely indicative and may differ in graphics, size or content . Even the names of the products, the ingredients and the percentages described are purely indicative and the manufacturing companies could make changes or updates. The only element of identification is the ministerial code MINSAN. Pharmaserena declines all responsibility for any errors, omissions or lack of product updates.